Accessibility: Skip TopNav
Figure 1
Historical declines on ADAS-Cog over 18 months in Alzheimer's disease (MMSE 20-30), placebo arms vs simufilam treatment.
Format
JPEG
Source
Cassava Sciences, Inc.
Downloads
Original
Large
Medium
Small